CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) is a publicly traded Healthcare sector company. As of May 21, 2026, CASI trades at $0.21 with a market cap of $4.26M and a P/E ratio of -0.78. CASI moved -38.97% today. Year to date, CASI is -89.88%; over the trailing twelve months it is -91.09%. Its 52-week range spans $0.21 to $7.50. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces CASI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CASI moved -38.97% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.21 |
| Market Cap | $4.26M |
| P/E Ratio | -0.78 |
| EPS | $-0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.50 |
| 52-Week Low | $0.21 |
| Volume | 9.96M |
| Avg Volume | 0 |
| Revenue (TTM) | $30.17M |
| Net Income | $-35.84M |
| Gross Margin | 58.38% |
6 analysts cover CASI: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.